SLC16A1 and acute myeloid leukemia: By blocking Monocarboxylic Acid Transporter 1 (MCT1), lactate transport inhibition significantly heightens the sensitivity of AML cells to mitochondrial electron transport chain (ETC) complex II inhibition [132].